All Krystal Biotech articles

  • shutterstock_1659535552 (1)
    Article

    Year in review: EPR’s top stories of 2023

    2023-12-18T10:00:11Z

    EPR wraps up the year with a selection of top stories from 2023, highlighting key trends and topics such as environmental monitoring (EM), quality (QA/QC), manufacturing, regulation and clinical development.

  • redosable gene therapy
    News

    First redosable gene therapy approved

    2023-05-24T11:54:17Z

    The “landmark approval” of a redosable gene therapy for dystrophic epidermolysis bullosa “ushers in a whole new paradigm to treat genetic diseases".